{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:13:11Z","timestamp":1782771191807,"version":"3.54.5"},"reference-count":61,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Am Coll Clin Pharm"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Co\u2010existence of multiple cardiovascular\u2010kidney\u2010metabolic (CKM) conditions, such as chronic kidney disease (CKD), type 2 diabetes (T2D), and cardiovascular disease, is common. The interconnected nature of CKM conditions emphasizes the need for an interprofessional approach to patient care. As the prevalence of people with CKM conditions continues to rise in the United States and the burden on the health care system increases, clinical pharmacists are well\u2010positioned to provide support within interprofessional teams and improve patient access to care through delivery of education, assessments and monitoring, and optimal initiation and maintenance of guideline\u2010directed medical therapy (GDMT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This scoping review explored interprofessional team\u2010based interventions that incorporated pharmacists into the management of CKM conditions in the U.S. Searches were conducted in Embase and MEDLINE for relevant studies published in English between January 1, 2015 and February 14, 2025, in a patient population with &gt;\u20095% of patients with both CKD and one or more cardiovascular or metabolic conditions. Outcomes investigated included estimated glomerular filtration rate, urine albumin\u2010to\u2010creatinine ratio, glycated hemoglobin, and systolic and diastolic blood pressure, as well as patient and physician satisfaction with pharmacist interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 28 studies met the eligibility criteria,\u00a0including 18 randomized clinical trials, 4 pilot studies, and 6 observational studies. Effective interventions generally included longitudinal follow\u2010up with multiple pharmacist visits over time, comprehensive pharmacist involvement including patient assessment, monitoring, and medication management, and direct deployment of pharmacist\u2010led interventions through collaborative practice agreements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This scoping review demonstrates an integral and direct role for pharmacists in improving outcomes for patients with CKM conditions in interprofessional settings. However, there is a need for more robust studies that investigate cardiovascular, kidney, and metabolic outcomes in these patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jac5.70198","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:23:51Z","timestamp":1773282231000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Scoping Review of Pharmacist\u2010Based Interprofessional Interventions for Management of Cardiovascular\u2010Kidney\u2010Metabolic Conditions"],"prefix":"10.1002","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2201-3019","authenticated-orcid":false,"given":"Wendy L.","family":"St. Peter","sequence":"first","affiliation":[{"name":"College of Pharmacy, University of Minnesota  Minneapolis Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4734-7402","authenticated-orcid":false,"given":"Joshua J.","family":"Neumiller","sequence":"additional","affiliation":[{"name":"College of Pharmacy and Pharmaceutical Sciences, Washington State University  Spokane Washington USA"},{"name":"Providence Medical Research Center, Providence Health Care University of Washington  Spokane Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radica","family":"Alicic","sequence":"additional","affiliation":[{"name":"Providence Medical Research Center, Providence Health Care University of Washington  Spokane Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl L.","family":"Chow","sequence":"additional","affiliation":[{"name":"Pharmacy Practice and Administration Western University of Health Sciences  Pomona California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadley","family":"Dowell","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Minnesota  Minneapolis Minnesota USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Kenrik","family":"Duru","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine University of California  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Gee","sequence":"additional","affiliation":[{"name":"Patient Author, iAdvocate, Inc.  North Chesterfield Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy O.","family":"Mathew","sequence":"additional","affiliation":[{"name":"Loma Linda VA Health Care System  Loma Linda California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne B.","family":"Nicholas","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine University of California  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janani","family":"Rangaswami","sequence":"additional","affiliation":[{"name":"George Washington University School of Medicine and Health Sciences  Washington DC USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda V.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Patient Author, Mount Sinai Center for Kidney Disease Innovation, Icahn School of Medicine at Mount Sinai  New York New York USA"},{"name":"Kidney Research Institute, University of Washington  Seattle Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital Heart &amp; Vascular Center, Harvard Medical School  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R.","family":"Tuttle","sequence":"additional","affiliation":[{"name":"Providence Medical Research Center, Providence Health Care University of Washington  Spokane Washington USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"e_1_2_12_2_1","unstructured":"U.S. Centers for Disease Control and Prevention \u201cKidney Diseases Surveillance System. Trends in Prevalence of CKD Stages Among U.S. Adults \u201daccessed May 27 2025 https:\/\/nccd.cdc.gov\/CKD\/detail.aspx?Qnum=Q372."},{"key":"e_1_2_12_3_1","unstructured":"U.S. Centers for Disease Control and Prevention \u201cKidney Diseases Surveillance System. Trends in Prevalence of CKD among U.S. Adults \u201daccessed May 27 2025 https:\/\/nccd.cdc.gov\/CKD\/detail.aspx?Qnum=Q9&topic=1#refreshPosition."},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000102971.85504.7c"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2021.100822"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.6.659"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51362"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad445"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2021.11.003"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000664"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001184"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000001040"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.122.059595"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/circoutcomes.120.007264"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2019.3796"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41581\u2010019\u20100240\u20106"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15194"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2022.28.1.85"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7647"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.7326\/m18\u20100850"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2025.100671"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/emermed\u20102020\u2010209567"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_2_12_25_1","unstructured":"G. A.Wells B.Shea D.O'Connell et\u00a0al. \u201cThe Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality if Nonrandomized Studies in Meta\u2010Analyses \u201daccessed June 18 2025 http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm."},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2016.09.004"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2018.07.001"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.124.069494"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1161\/circoutcomes.114.001283"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2083"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.121.17873"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882\u2010016\u20100383\u20107"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882\u2010015\u20100052\u20102"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/10600280211023492"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190016641491"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/circoutcomes.117.004386"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12902\u2010022\u201000983\u2010y"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2019.05.010"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40814\u2010019\u20100410\u20100"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.01.018"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.0708"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/jch.14372"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12882\u2010017\u20100541\u20106"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.05050419"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.05.013"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1159\/000448294"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/10641963.2017.1411493"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190019876499"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190018824820"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2022.11.007"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606\u2010019\u201005403\u2010x"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1097\/mlr.0000000000001387"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/mlr.0000000000002043"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1477729"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.113.000718"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2023.108091"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae221"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2016.22.5.493"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15279"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/jac5.1309"},{"key":"e_1_2_12_61_1","unstructured":"American College of Clinical Pharmacy \u201cACCP Practice Advancement Issue Brief. Collaborative Practice Agreements in Outpatient Team\u2010Based Clinical Pharmacy Practice \u201daccessed January 13 2026 https:\/\/www.accp.com\/docs\/positions\/misc\/IB2CPA\u2010ACCPPracticeAdvancement.pdf."},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjcafi.2025.05.001"}],"container-title":["JACCP:  JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jac5.70198","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jac5.70198","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jac5.70198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T01:21:32Z","timestamp":1775611292000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/jac5.70198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1002\/jac5.70198"],"URL":"https:\/\/doi.org\/10.1002\/jac5.70198","archive":["Portico"],"relation":{},"ISSN":["2574-9870","2574-9870"],"issn-type":[{"value":"2574-9870","type":"print"},{"value":"2574-9870","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"2025-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70198"}}